Claire specialises in commercial arrangements that involve the development and commercialisation of intellectual property rights and in corporate and investment deals where IP is an important asset. She advises on a wide variety of commercial and intellectual property transactions (the large majority of which are cross-border) across a range of industries, most notably in the life sciences, technology, media and consumer product sectors.

Examples of her recent experience include advising:

• life science companies on agreements for the licensing and development of novel compounds (both with commercial organisations and academic institutions)
• leading pharmaceutical companies on acquisitions and disposals of rights in pharmaceutical products and on related arrangements for the supply of products, including the manufacture of active pharmaceutical ingredients (APIs)
• SMEs and multinational companies on supply and distribution agreements for a wide range of consumer products
• medical device, digital health and engineering companies on joint ventures, collaborations and strategic partnerships
• a well-known global technology company on the IP aspects of its acquisitions of e-commerce and software platforms
• a fast-growing start-up on the IP and commercial arrangements relating to the creation, protection and exploitation of a new children’s character.

Before becoming a lawyer, Claire spent a number of years working for Abbott Laboratories’ medical device business. She started out in the company’s quality assurance team, and then moved into its operations division to become a project manager.  Since being at Bristows, Claire has also spent time seconded to the in-house legal team of a leading global pharmaceutical company.

Claire is the co-editor of Getting the Deal Through – Licensing, a comprehensive multi-jurisdictional guide to IP licensing laws. She is also a member of the UK BioIndustry Association’s Intellectual Property Advisory Committee.